These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differentiation between renal allograft rejection and cyclosporine toxicity: a clinicopathological study. Alexopoulos E; Leontsini M; Daniilidis M; Sakellariou G; Visvardis G; Papadimitriou M Am J Kidney Dis; 1991 Jul; 18(1):108-15. PubMed ID: 2063842 [TBL] [Abstract][Full Text] [Related]
5. Morphology of cyclosporine nephrotoxicity and acute rejection in patients immunosuppressed with cyclosporine and prednisone. Sibley RK; Rynasiewicz J; Ferguson RM; Fryd D; Sutherland DE; Simmons RL; Najarian JS Surgery; 1983 Aug; 94(2):225-34. PubMed ID: 6348988 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity. te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883 [TBL] [Abstract][Full Text] [Related]
7. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants. Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264 [TBL] [Abstract][Full Text] [Related]
8. Acute cellular rejection or Cyclosporine A nephrotoxicity? A review of transplant renal biopsies. Verani RR; Flechner SM; Van Buren CT; Kahan BD Am J Kidney Dis; 1984 Sep; 4(2):185-91. PubMed ID: 6383031 [TBL] [Abstract][Full Text] [Related]
9. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity. Fuggle SV; McWhinnie DL; Morris PJ Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Woodle ES; Cronin D; Newell KA; Millis JM; Bruce DS; Piper JB; Haas M; Josephson MA; Thistlethwaite JR Transplantation; 1996 Oct; 62(7):906-10. PubMed ID: 8878382 [TBL] [Abstract][Full Text] [Related]
11. Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Klintmalm G; Bohman SO; Sundelin B; Wilczek H Lancet; 1984 Oct; 2(8409):950-4. PubMed ID: 6149343 [TBL] [Abstract][Full Text] [Related]
12. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology]. Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106 [TBL] [Abstract][Full Text] [Related]
13. [Biopsy findings in kidney transplants after treatment with cyclosporin A]. Nizze H; Gokel JM; Lang W; Mihatsch MJ Zentralbl Allg Pathol; 1986; 132(5-6):423-33. PubMed ID: 3551394 [TBL] [Abstract][Full Text] [Related]
14. Blood cyclosporin concentrations and renal allograft dysfunction. Holt DW; Marsden JT; Johnston A; Bewick M; Taube DH Br Med J (Clin Res Ed); 1986 Oct; 293(6554):1057-9. PubMed ID: 3094774 [TBL] [Abstract][Full Text] [Related]
15. Acute cellular rejection and cyclosporine nephrotoxicity monitored by biopsy in a renal allograft recipient. The differentiation of drug nephrotoxicity from rejection by phenotyping of cellular infiltrates. Kolbeck PC; Scheinman JI; Sanfilippo F Arch Pathol Lab Med; 1986 May; 110(5):389-93. PubMed ID: 3516116 [TBL] [Abstract][Full Text] [Related]
16. Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients. Prischl F; Gremmel F; Schwabe M; Schindler J; Balcke P; Kopsa H; Pinter G; Schwarzmeier J; Zazgornik J Nephron; 1989; 51(3):330-7. PubMed ID: 2645532 [TBL] [Abstract][Full Text] [Related]
17. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity. Yilmaz S; Taskinen E; Paavonen T; Mennander A; Häyry P Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245 [TBL] [Abstract][Full Text] [Related]
18. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clin Nephrol; 1985 Sep; 24(3):107-19. PubMed ID: 3899437 [TBL] [Abstract][Full Text] [Related]
19. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Farnsworth A; Hall BM; Ng AB; Duggin GG; Horvath JS; Sheil AG; Tiller DJ Am J Surg Pathol; 1984 Apr; 8(4):243-52. PubMed ID: 6369996 [TBL] [Abstract][Full Text] [Related]